Radio-223 en la secuencia terapéutica del cáncer de próstata resistente a la castración metastásico

Radium-223 can be a treatment option for patients with mild symptoms and can provide a therapeutic benefit after failure of currently available treatments or in combination with these treatments. This evidence should be corroborated in clinical trials before being added to clinical practice.